Bionik Laboratories Corp. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Bionik Laboratories Corp. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q1 2023.
  • Bionik Laboratories Corp. Common Stock, Shares Authorized for the quarter ending March 31, 2023 was 13M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 13M 0 0% Mar 31, 2023 10-K 2023-06-21
Q4 2022 13M 0 0% Dec 31, 2022 10-Q 2023-02-08
Q3 2022 13M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 13M 0 0% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 13M 0 0% Mar 31, 2022 10-K 2023-06-21
Q4 2021 13M 0 0% Dec 31, 2021 10-Q 2022-02-09
Q3 2021 13M -487M -97.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 13M -487M -97.4% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 13M -487M -97.4% Mar 31, 2021 10-K 2022-06-09
Q4 2020 13M -487M -97.4% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 500M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 500M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 500M 0 0% Mar 31, 2020 10-K 2021-06-24
Q4 2019 500M 0 0% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 500M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 500M 0 0% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 500M +250M +100% Mar 31, 2019 10-K 2020-06-30
Q4 2018 500M +250M +100% Dec 31, 2018 10-Q 2019-02-11
Q3 2018 500M +250M +100% Sep 30, 2018 10-Q 2019-02-11
Q2 2018 500M +350M +233% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 250M +100M +66.7% Mar 31, 2018 10-Q 2020-11-12
Q4 2017 250M +100M +66.7% Dec 31, 2017 10-Q 2018-02-13
Q3 2017 250M +100M +66.7% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 150M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 150M 0 0% Mar 31, 2017 10-Q 2020-11-12
Q4 2016 150M 0 0% Dec 31, 2016 10-Q 2017-02-14
Q3 2016 150M 0 0% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 150M 0 0% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 150M 0 0% Mar 31, 2016 8-K 2017-12-21
Q4 2015 150M -50M -25% Dec 31, 2015 10-KT 2016-06-30
Q3 2015 150M Sep 30, 2015 10-Q/A 2016-03-17
Q2 2015 150M Jun 30, 2015 10-Q/A 2016-03-17
Q1 2015 150M Mar 31, 2015 10-KT 2016-06-30
Q4 2014 200M 0 0% Dec 31, 2014 10-Q 2020-11-12
Q4 2013 200M +155M +344% Dec 31, 2013 10-KT 2016-06-30
Q3 2013 200M Sep 30, 2013 10-Q 2013-11-14
Q2 2013 200M Jun 30, 2013 10-Q 2013-08-14
Q1 2013 45M 0 0% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 45M 0 0% Dec 31, 2012 10-Q 2013-05-15
Q1 2012 45M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 45M 0 0% Dec 31, 2011 10-K 2013-03-06
Q4 2010 45M Dec 31, 2010 10-K 2012-04-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.